Align Technology, Inc. (ALGN)
USD 152.83
(-0.91%)
USD 152.83
(-0.91%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.86 Billion USD | 3.42% |
| 2022 | 3.73 Billion USD | -5.51% |
| 2021 | 3.95 Billion USD | 59.9% |
| 2020 | 2.47 Billion USD | 2.71% |
| 2019 | 2.4 Billion USD | 22.39% |
| 2018 | 1.96 Billion USD | 33.47% |
| 2017 | 1.47 Billion USD | 36.44% |
| 2016 | 1.07 Billion USD | 27.72% |
| 2015 | 845.48 Million USD | 11.01% |
| 2014 | 761.65 Million USD | 15.37% |
| 2013 | 660.2 Million USD | 17.89% |
| 2012 | 560.04 Million USD | 16.74% |
| 2011 | 479.74 Million USD | 23.92% |
| 2010 | 387.12 Million USD | 23.95% |
| 2009 | 312.33 Million USD | 2.75% |
| 2008 | 303.97 Million USD | 6.91% |
| 2007 | 284.33 Million USD | 37.79% |
| 2006 | 206.35 Million USD | -0.37% |
| 2005 | 207.12 Million USD | 19.84% |
| 2004 | 172.83 Million USD | 40.83% |
| 2003 | 122.72 Million USD | 62.78% |
| 2002 | 75.39 Million USD | 62.55% |
| 2001 | 46.38 Million USD | 588.09% |
| 2000 | 6.74 Million USD | 1540.15% |
| 1999 | 411 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 997.43 Million USD | 4.25% |
| 2024 Q3 | 977.87 Million USD | -4.92% |
| 2024 Q2 | 1.02 Billion USD | 3.11% |
| 2023 Q4 | 956.72 Million USD | -0.36% |
| 2023 Q1 | 943.14 Million USD | 4.62% |
| 2023 Q2 | 1 Billion USD | 6.26% |
| 2023 Q3 | 960.21 Million USD | -4.19% |
| 2023 FY | 3.86 Billion USD | 3.42% |
| 2022 Q3 | 890.34 Million USD | -8.17% |
| 2022 FY | 3.73 Billion USD | -5.51% |
| 2022 Q4 | 901.51 Million USD | 1.25% |
| 2022 Q2 | 969.55 Million USD | -0.38% |
| 2022 Q1 | 973.21 Million USD | -5.61% |
| 2021 Q3 | 1.01 Billion USD | 0.5% |
| 2021 Q4 | 1.03 Billion USD | 1.5% |
| 2021 Q2 | 1.01 Billion USD | 12.97% |
| 2021 Q1 | 894.77 Million USD | 7.22% |
| 2021 FY | 3.95 Billion USD | 59.9% |
| 2020 FY | 2.47 Billion USD | 2.71% |
| 2020 Q4 | 834.52 Million USD | 13.67% |
| 2020 Q2 | 352.31 Million USD | -36.05% |
| 2020 Q1 | 550.96 Million USD | -15.21% |
| 2020 Q3 | 734.14 Million USD | 108.38% |
| 2019 Q2 | 600.69 Million USD | 9.42% |
| 2019 Q1 | 548.97 Million USD | 2.8% |
| 2019 Q3 | 607.34 Million USD | 1.11% |
| 2019 Q4 | 649.78 Million USD | 6.99% |
| 2019 FY | 2.4 Billion USD | 22.39% |
| 2018 Q1 | 436.92 Million USD | 3.7% |
| 2018 FY | 1.96 Billion USD | 33.47% |
| 2018 Q2 | 490.25 Million USD | 12.21% |
| 2018 Q3 | 505.28 Million USD | 3.07% |
| 2018 Q4 | 534.02 Million USD | 5.69% |
| 2017 Q1 | 310.34 Million USD | 5.85% |
| 2017 FY | 1.47 Billion USD | 36.44% |
| 2017 Q2 | 356.48 Million USD | 14.87% |
| 2017 Q3 | 385.26 Million USD | 8.07% |
| 2017 Q4 | 421.32 Million USD | 9.36% |
| 2016 Q2 | 269.36 Million USD | 12.84% |
| 2016 FY | 1.07 Billion USD | 27.72% |
| 2016 Q4 | 293.2 Million USD | 5.25% |
| 2016 Q3 | 278.58 Million USD | 3.43% |
| 2016 Q1 | 238.72 Million USD | 3.67% |
| 2015 Q4 | 230.27 Million USD | 10.9% |
| 2015 FY | 845.48 Million USD | 11.01% |
| 2015 Q1 | 198.08 Million USD | -0.26% |
| 2015 Q2 | 209.48 Million USD | 5.76% |
| 2015 Q3 | 207.63 Million USD | -0.88% |
| 2014 FY | 761.65 Million USD | 15.37% |
| 2014 Q2 | 192.53 Million USD | 6.58% |
| 2014 Q1 | 180.64 Million USD | 1.32% |
| 2014 Q3 | 189.87 Million USD | -1.38% |
| 2014 Q4 | 198.6 Million USD | 4.59% |
| 2013 Q3 | 164.5 Million USD | 0.41% |
| 2013 Q1 | 153.58 Million USD | 7.52% |
| 2013 FY | 660.2 Million USD | 17.89% |
| 2013 Q4 | 178.29 Million USD | 8.38% |
| 2013 Q2 | 163.82 Million USD | 6.67% |
| 2012 Q3 | 136.49 Million USD | -6.27% |
| 2012 Q4 | 142.84 Million USD | 4.65% |
| 2012 Q1 | 135.07 Million USD | 4.79% |
| 2012 FY | 560.04 Million USD | 16.74% |
| 2012 Q2 | 145.62 Million USD | 7.81% |
| 2011 FY | 479.74 Million USD | 23.92% |
| 2011 Q1 | 104.85 Million USD | 12.88% |
| 2011 Q2 | 120.08 Million USD | 14.52% |
| 2011 Q3 | 125.89 Million USD | 4.84% |
| 2011 Q4 | 128.9 Million USD | 2.39% |
| 2010 Q4 | 92.89 Million USD | -3.18% |
| 2010 FY | 387.12 Million USD | 23.95% |
| 2010 Q2 | 108.19 Million USD | 20.1% |
| 2010 Q1 | 90.09 Million USD | 4.01% |
| 2010 Q3 | 95.94 Million USD | -11.32% |
| 2009 Q2 | 76.31 Million USD | 8.82% |
| 2009 FY | 312.33 Million USD | 2.75% |
| 2009 Q3 | 79.26 Million USD | 3.87% |
| 2009 Q4 | 86.61 Million USD | 9.27% |
| 2009 Q1 | 70.13 Million USD | -5.39% |
| 2008 Q4 | 74.12 Million USD | -1.39% |
| 2008 FY | 303.97 Million USD | 6.91% |
| 2008 Q3 | 75.17 Million USD | -5.92% |
| 2008 Q2 | 79.9 Million USD | 6.86% |
| 2008 Q1 | 74.77 Million USD | 3.12% |
| 2007 Q1 | 63.76 Million USD | 15.53% |
| 2007 Q2 | 76.6 Million USD | 20.14% |
| 2007 Q3 | 71.45 Million USD | -6.73% |
| 2007 FY | 284.33 Million USD | 37.79% |
| 2007 Q4 | 72.51 Million USD | 1.49% |
| 2006 Q4 | 55.19 Million USD | 12.56% |
| 2006 FY | 206.35 Million USD | -0.37% |
| 2006 Q3 | 49.03 Million USD | -7.87% |
| 2006 Q1 | 48.9 Million USD | -4.41% |
| 2006 Q2 | 53.22 Million USD | 8.82% |
| 2005 FY | 207.12 Million USD | 19.84% |
| 2005 Q1 | 51.15 Million USD | 17.18% |
| 2005 Q2 | 53.94 Million USD | 5.44% |
| 2005 Q4 | 51.16 Million USD | 0.59% |
| 2005 Q3 | 50.86 Million USD | -5.7% |
| 2004 FY | 172.83 Million USD | 40.83% |
| 2004 Q1 | 39.2 Million USD | 7.41% |
| 2004 Q2 | 44.2 Million USD | 12.75% |
| 2004 Q3 | 45.76 Million USD | 3.53% |
| 2004 Q4 | 43.65 Million USD | -4.61% |
| 2003 FY | 122.72 Million USD | 62.78% |
| 2003 Q2 | 29.22 Million USD | 18.15% |
| 2003 Q4 | 36.5 Million USD | 7.24% |
| 2003 Q1 | 24.73 Million USD | 10.3% |
| 2003 Q3 | 34.03 Million USD | 16.47% |
| 2002 Q1 | 17.14 Million USD | 39.36% |
| 2002 FY | 75.39 Million USD | 62.55% |
| 2002 Q4 | 22.42 Million USD | 20.75% |
| 2002 Q3 | 18.57 Million USD | 7.64% |
| 2002 Q2 | 17.25 Million USD | 0.67% |
| 2001 Q2 | 13.48 Million USD | 75.35% |
| 2001 Q1 | 7.68 Million USD | 0.0% |
| 2001 FY | 46.38 Million USD | 588.09% |
| 2001 Q4 | 12.3 Million USD | -4.74% |
| 2001 Q3 | 12.91 Million USD | -4.23% |
| 2000 FY | 6.74 Million USD | 1540.15% |
| 2000 Q1 | 629 Thousand USD | 0.0% |
| 1999 FY | 411 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -31928.029% |
| BrainsWay Ltd. | 31.78 Million USD | -12051.203% |
| Cerus Corporation | 156.36 Million USD | -2369.997% |
| Envoy Medical, Inc. | 316 Thousand USD | -1222134.177% |
| electroCore, Inc. | 16.03 Million USD | -23993.949% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -599629.814% |
| IceCure Medical Ltd | 3.22 Million USD | -119511.644% |
| Inogen, Inc. | 315.66 Million USD | -1123.551% |
| OrthoPediatrics Corp. | 148.73 Million USD | -2496.792% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -158971.664% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -1058056.324% |
| MaxCyte, Inc. | 41.28 Million USD | -9254.437% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -197716.989% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -3487330.924% |
| Orthofix Medical Inc. | 746.64 Million USD | -417.285% |
| PAVmed Inc | 2.45 Million USD | -157414.682% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -17051.117% |
| RxSight, Inc. | 89.07 Million USD | -4235.867% |
| Sight Sciences, Inc. | 81.05 Million USD | -4664.928% |
| SI-BONE, Inc. | 138.88 Million USD | -2680.885% |
| TELA Bio, Inc. | 58.45 Million USD | -6507.462% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -1964.077% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -27885.363% |
| Acutus Medical, Inc. | 7.16 Million USD | -53812.06% |
| Talis Biomedical Corporation | 412 Thousand USD | -937341.748% |
| Spectral AI, Inc. | 18.05 Million USD | -21290.452% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -38893.034% |
| CVRx, Inc. | 39.29 Million USD | -9728.884% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -398603.012% |
| Bioventus Inc. | 512.34 Million USD | -653.84% |
| Venus Concept Inc. | 76.35 Million USD | -4958.36% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -20764.675% |
| LivaNova PLC | 1.15 Billion USD | -234.817% |
| 908 Devices Inc. | 50.22 Million USD | -7589.303% |
| Alphatec Holdings, Inc. | 482.26 Million USD | -700.863% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -5012957.474% |
| NeuroPace, Inc. | 65.42 Million USD | -5803.701% |
| LENSAR, Inc. | 42.16 Million USD | -9060.089% |
| Apyx Medical Corporation | 52.34 Million USD | -7277.906% |
| Cutera, Inc. | 212.36 Million USD | -1718.655% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -11478.212% |
| BioSig Technologies, Inc. | 18 Thousand USD | -21456900.0% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -2217.421% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -16022.981% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | -150.54% |
| Axonics, Inc. | 366.37 Million USD | -954.171% |
| Outset Medical, Inc. | 130.37 Million USD | -2862.401% |
| IRIDEX Corporation | 51.86 Million USD | -7346.182% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -2735.914% |
| IRadimed Corporation | 65.56 Million USD | -5790.977% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -328323.469% |
| INVO Bioscience, Inc. | 3.02 Million USD | -127765.059% |
| Telesis Bio, Inc. | 27.5 Million USD | -13939.987% |
| Viemed Healthcare, Inc. | 183 Million USD | -2010.432% |
| Varex Imaging Corporation | 811 Million USD | -376.234% |
| Quipt Home Medical Corp. | 221.74 Million USD | -1641.781% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -5523.968% |
| Dynatronics Corporation | 32.53 Million USD | -11771.47% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -44406.338% |
| Semler Scientific, Inc. | 68.18 Million USD | -5564.467% |
| InMode Ltd. | 492.04 Million USD | -684.936% |
| Bruker Corporation | 2.96 Billion USD | -30.284% |
| Cytosorbents Corporation | 36.34 Million USD | -10525.381% |
| DexCom, Inc. | 3.62 Billion USD | -6.625% |
| Viveve Medical, Inc. | 6.42 Million USD | -60003.641% |
| ZimVie Inc. | 457.43 Million USD | -744.333% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -1901.015% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -3487330.924% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | -416.54% |
| Profound Medical Corp. | 7.33 Million USD | -52583.794% |
| Insulet Corporation | 1.69 Billion USD | -127.58% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -2963.389% |
| iCAD, Inc. | 17.31 Million USD | -22201.998% |
| Nuwellis, Inc. | 8.86 Million USD | -43472.428% |
| Biotricity, Inc. | 12.06 Million USD | -31916.493% |
| iRhythm Technologies, Inc. | 492.68 Million USD | -683.927% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -62144.319% |
| PAVmed Inc. | 2.45 Million USD | -157414.682% |
| BIOLASE, Inc. | 49.16 Million USD | -7755.87% |
| Beyond Air, Inc. | 1.15 Million USD | -333140.725% |
| FONAR Corporation | 102.88 Million USD | -3653.992% |
| AxoGen, Inc. | 159.01 Million USD | -2328.911% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -1307.411% |
| Inari Medical, Inc. | 493.63 Million USD | -682.417% |
| UFP Technologies, Inc. | 400.07 Million USD | -865.391% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -20764738.71% |
| Tenon Medical, Inc. | 2.92 Million USD | -131807.787% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -56597.57% |
| AdaptHealth Corp. | 3.2 Billion USD | -20.689% |
| Sintx Technologies, Inc. | 2.62 Million USD | -146921.698% |
| NanoVibronix, Inc. | 2.28 Million USD | -169074.77% |
| Quanterix Corporation | 122.36 Million USD | -3056.266% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -15725.691% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -1826.112% |
| TransMedics Group, Inc. | 241.62 Million USD | -1498.465% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -27778.302% |
| NeuroMetrix, Inc. | 5.9 Million USD | -65346.227% |
| Hyperfine, Inc. | 11.03 Million USD | -34909.608% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -2238.623% |
| Biomerica, Inc. | 5.41 Million USD | -71225.208% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -7538.812% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -2080.417% |